Hence, we recommend the convenient, economical, relatively non-invasive, and reproducible detection of TrxR activity levels, along with CEA, NSE, and Cyfra21-1, to aid in diagnosis of NSCLC. This evidence concerns the gene ENO2 and non-small cell lung carcinoma.